Related references
Note: Only part of the references are listed.Toxic liver injury after high-dose methylprednisolone in people with multiple sclerosis
Ivan Adamec et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2018)
Methimazole-induced liver injury overshadowed by methylprednisolone pulse therapy Case report
Silvijus Abramavicius et al.
MEDICINE (2017)
Methylprednisolone liver toxicity: A new case and a French regional pharmacovigilance survey
Jerome Dumortier et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2017)
Hepatotoxicity after high-dose intravenous methylprednisolone in multiple sclerosis patients
Milagros Hidalgo de la Cruz et al.
CLINICAL CASE REPORTS (2017)
Methylprednisolone-induced liver injury: Case report and literature review
Yana Davidov et al.
JOURNAL OF DIGESTIVE DISEASES (2016)
Autoantibody presentation in drug-induced liver injury and idiopathic autoimmune hepatitis: the influence of human leucocyte antigen alleles
Camilla Stephens et al.
PHARMACOGENETICS AND GENOMICS (2016)
Acute liver damage following intravenous glucocorticoid treatment for Graves' ophthalmopathy
Mariacarla Moleti et al.
ENDOCRINE (2016)
Methylprednisolone-induced Toxic Hepatitis After Intravenous Pulsed Therapy for Multiple Sclerosis Relapses
Diana Ferraro et al.
NEUROLOGIST (2015)
Incomplete septal cirrhosis after high-dose methylprednisolone therapy and regression of liver injury
Elisabetta Grilli et al.
LIVER INTERNATIONAL (2015)
Use of Hy's Law and a New Composite Algorithm to Predict Acute Liver Failure in Patients With Drug-Induced Liver Injury
Mercedes Robles-Diaz et al.
GASTROENTEROLOGY (2014)
Acute liver toxicity due to methylprednisolone: Consider this diagnosis in the context of autoimmunity
P. Carrier et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2013)
Liver Injury Induced by High-Dose Methylprednisolone Therapy: A Case Report and Brief Review of the Literature
Krzysztof Gutkowski et al.
Hepatitis Monthly (2011)
Recurrent High-Dose Intravenous Methylprednisolone Succinate Pulse Therapy-Induced Hepatopathy in a Patient with Multiple Sclerosis
Daisuke Furutama et al.
MEDICAL PRINCIPLES AND PRACTICE (2011)
Hepatotoxicity After High-Dose Methylprednisolone for Demyelinating Disease
Anna Loraschi et al.
CLINICAL NEUROPHARMACOLOGY (2010)
Toxicidad hepática recurrente secundaria a metilprednisolona intravenosa
M. Rivero Fernández et al.
REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS (2010)
Rechallenge in drug-induced liver injury: the attractive hazard
Raul J. Andrade et al.
EXPERT OPINION ON DRUG SAFETY (2009)
Pulsed methylpresnisolone revealed autoimmune hepatitis in a patient with multiple sclerosis
N. Maamouri et al.
JOURNAL AFRICAIN D HEPATO-GASTROENTEROLOGIE (2009)
Development of autoimmune hepatitis type 1 after pulsed methylprednisolone therapy for multiple sclerosis: A case report
Atsushi Takahashi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Pericentral liver cell necrosis associated with the use of high-dose intravenous methylprednisolone
Hannah M. Lee et al.
DIGESTIVE DISEASES AND SCIENCES (2007)
Methylprednisolone-induced toxic hepatitis
Firdevs Topal et al.
ANNALS OF PHARMACOTHERAPY (2006)
Autoimmune hepatitis during intravenous glucocorticoid pulse therapy for Graves' ophthalmopathy treated successfully with glucocorticoids themselves
M Marinò et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2005)
Onset of autoimmune hepatitis during intravenous steroid therapy for thyroid-associated ophthalmopathy in a patient with Hashimoto's thyroiditis: Case report
M Salvi et al.
THYROID (2004)
Acute and severe liver damage associated with intravenous glucocorticoid pulse therapy in patients with Graves' ophthalmopathy
M Marinó et al.
THYROID (2004)
Fatal liver failure after high-dose glucocorticoid pulse therapy in a patient with severe thyroid eye disease
M Weissel et al.
THYROID (2000)